Good Clinical Podcast: Season 3, Episode 4
The Importance of Risk-based Quality Management, Centralized Monitoring, and Strategic SDV/SDR Sampling
What does clinical trial monitoring have in common with growing a field of corn? Tune into this week’s podcast episode to find out!
Amy Kroeplin (Sr. Director Centralized Monitoring, RBQM Global Process Owner, PPD™ clinical research business of Thermo Fisher Scientific), Shailesh Madel (Director, Clinical Risk Management, ICON plc), and Nicole Stansbury (Sr. Vice President, Global Clinical Operations, Premier Research) join the podcast to discuss the importance of risk-based quality management, centralized monitoring, and strategic SDV/SDR sampling strategies.
They dive deeper into the unique roles of SDV and SDR, different methods of implementing SDV/SDR sampling strategies, and the industry imperative to increase centralized monitoring adoption.
This episode is available to stream on Spotify, Apple Podcasts, and YouTube.